Chris Kemmerer, Ph.D.
Vice President, Pharmaceutical Development and Manufacturing
Chris Kemmerer, Ph.D. serves as our Vice President of Pharmaceutical Development and Manufacturing with 20 years of experience in the pharmaceutical industry. In this capacity, Chris is primarily responsible for developing our drug product formulations and providing pre-clinical and clinical supplies. Prior to joining Lithera, Chris held the position of Director of Pharmaceutical Development at Avera Pharmaceuticals developing controlled release formulations and formulations of poorly water-soluble drug candidates. Prior to Avera, Chris held positions of increasing responsibility at Pfizer, Inc, La Jolla, CA and was responsible for process and development activities for Diabetes drug candidates. Prior to joining Pfizer, Inc. Chris held positions across numerous functional areas of drug development at Merck & Company in West Point, PA, including in process and formulation development, scale-up , and manufacturing roles. In these capacities, Chris was an important contributor to the development of Emend® and oversaw the manufacturing of over 20 commercial drug products including Pepcid®, Prilosec®, and Nexium®. Chris earned a B.S. in Chemistry from Pennsylvania State University and a Ph.D. in Pharmaceuticals Sciences from Temple University in Philadelphia, PA. [Back to Management]
